KCNK18 and migraine disorder: Future studies are needed to examine coexpression of TRESK and TREK, to determine whether endogenous levels of TRESK-MT2 in human nociceptors inhibit TREK-1/2, and to evaluate the contribution of TREK-1/2 to migraine pathogenesis.